Clinical Trials Directory

Trials / Completed

CompletedNCT00161161

Genetic Liability in the Brain Morphology of Attention Deficit Hyperactivity Disorder

Status
Completed
Phase
Study type
Observational
Enrollment
90 (planned)
Sponsor
UMC Utrecht · Academic / Other
Sex
Male
Age
7 Years – 18 Years
Healthy volunteers
Accepted

Summary

Attention Deficit Hyperactivity Disorder (ADHD) is a heritable psychiatric disorder with onset in childhood. Twin and adoption studies indicate that additive genetic factors explain up to 80% of the variance underlying susceptibility. The siblings of children with ADHD have a three- to fivefold increased risk of having ADHD compared to the siblings of healthy control subjects, and the risk is even greater for monozygotic twins with 50-80% concordance compared with up to 33% in dizygotic twins). As full siblings share on average 50% of their genes, even the unaffected siblings of children with ADHD would be expected to share some of the genes involved in the disorder. The neuroanatomical substrate of ADHD is becoming increasingly better defined by a growing body of evidence from imaging studies. Evidence from neuroimaging studies suggests that this disorder is associated with reductions in brain volume up to 5% in these children. In this protocol we collected MRI-scans from boys with ADHD and their unaffected siblings, as well as control subjects. In addition, cheekswabs were later collected for DNA analysis.

Conditions

Timeline

Start date
1999-10-01
Completion
2002-12-01
First posted
2005-09-12
Last updated
2005-12-30

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT00161161. Inclusion in this directory is not an endorsement.

Genetic Liability in the Brain Morphology of Attention Deficit Hyperactivity Disorder (NCT00161161) · Clinical Trials Directory